S&P 500   4,593.68 (+0.57%)
DOW   36,223.95 (+0.76%)
QQQ   389.86 (+0.26%)
AAPL   191.04 (+0.57%)
MSFT   375.06 (-1.02%)
META   324.89 (-0.69%)
GOOGL   131.74 (-0.60%)
AMZN   147.02 (+0.64%)
TSLA   238.23 (-0.77%)
NVDA   468.11 (+0.09%)
NIO   7.22 (-0.69%)
BABA   74.09 (-1.06%)
AMD   121.00 (-0.13%)
T   16.70 (+0.78%)
F   10.57 (+3.02%)
MU   76.02 (-0.13%)
CGC   0.62 (+10.48%)
GE   122.51 (+0.58%)
DIS   92.35 (-0.37%)
AMC   6.96 (+4.66%)
PFE   28.82 (-5.42%)
PYPL   59.43 (+3.16%)
XOM   102.95 (+0.20%)
S&P 500   4,593.68 (+0.57%)
DOW   36,223.95 (+0.76%)
QQQ   389.86 (+0.26%)
AAPL   191.04 (+0.57%)
MSFT   375.06 (-1.02%)
META   324.89 (-0.69%)
GOOGL   131.74 (-0.60%)
AMZN   147.02 (+0.64%)
TSLA   238.23 (-0.77%)
NVDA   468.11 (+0.09%)
NIO   7.22 (-0.69%)
BABA   74.09 (-1.06%)
AMD   121.00 (-0.13%)
T   16.70 (+0.78%)
F   10.57 (+3.02%)
MU   76.02 (-0.13%)
CGC   0.62 (+10.48%)
GE   122.51 (+0.58%)
DIS   92.35 (-0.37%)
AMC   6.96 (+4.66%)
PFE   28.82 (-5.42%)
PYPL   59.43 (+3.16%)
XOM   102.95 (+0.20%)
S&P 500   4,593.68 (+0.57%)
DOW   36,223.95 (+0.76%)
QQQ   389.86 (+0.26%)
AAPL   191.04 (+0.57%)
MSFT   375.06 (-1.02%)
META   324.89 (-0.69%)
GOOGL   131.74 (-0.60%)
AMZN   147.02 (+0.64%)
TSLA   238.23 (-0.77%)
NVDA   468.11 (+0.09%)
NIO   7.22 (-0.69%)
BABA   74.09 (-1.06%)
AMD   121.00 (-0.13%)
T   16.70 (+0.78%)
F   10.57 (+3.02%)
MU   76.02 (-0.13%)
CGC   0.62 (+10.48%)
GE   122.51 (+0.58%)
DIS   92.35 (-0.37%)
AMC   6.96 (+4.66%)
PFE   28.82 (-5.42%)
PYPL   59.43 (+3.16%)
XOM   102.95 (+0.20%)
S&P 500   4,593.68 (+0.57%)
DOW   36,223.95 (+0.76%)
QQQ   389.86 (+0.26%)
AAPL   191.04 (+0.57%)
MSFT   375.06 (-1.02%)
META   324.89 (-0.69%)
GOOGL   131.74 (-0.60%)
AMZN   147.02 (+0.64%)
TSLA   238.23 (-0.77%)
NVDA   468.11 (+0.09%)
NIO   7.22 (-0.69%)
BABA   74.09 (-1.06%)
AMD   121.00 (-0.13%)
T   16.70 (+0.78%)
F   10.57 (+3.02%)
MU   76.02 (-0.13%)
CGC   0.62 (+10.48%)
GE   122.51 (+0.58%)
DIS   92.35 (-0.37%)
AMC   6.96 (+4.66%)
PFE   28.82 (-5.42%)
PYPL   59.43 (+3.16%)
XOM   102.95 (+0.20%)

Evaxion Biotech A/S (EVAX) Earnings Date, Estimates & Call Transcripts

$0.78
-0.02 (-2.35%)
(As of 03:15 PM ET)
Compare
Today's Range
$0.77
▼
$0.82
50-Day Range
$0.68
▼
$1.17
52-Week Range
$0.47
▼
$2.44
Volume
38,971 shs
Average Volume
274,363 shs
Market Capitalization
$21.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EVAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EVAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Evaxion Biotech A/S Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.30)($0.30)($0.30)
Q2 20231($0.30)($0.30)($0.30)
Q3 20231($0.32)($0.32)($0.32)
Q4 20231($0.35)($0.35)($0.35)
FY 20234($1.27)($1.27)($1.27)

EVAX Earnings Date and Information

Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 4th, 2023 based off prior year's report dates.

Evaxion Biotech A/S Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
12/4/2023
Estimated)		------- 
8/22/2023Q2 2023($0.22)($0.21)+$0.01($0.21)--  
5/31/2023Q1 2023($0.26)($0.24)+$0.02($0.24)--  
4/27/2023Q4 2022-($0.29)($0.29)($0.29)--
11/14/2022Q3 2022($0.34)($0.24)+$0.10($0.24)--
8/10/2022Q2 2022($0.33)($0.20)+$0.13($0.20)--
5/11/2022Q1 2022($0.35)($0.25)+$0.10($0.25)--    
3/22/2022Q4 2021($0.30)($0.39)($0.09)($0.39)--
11/9/2021Q3 2021($0.34)($0.27)+$0.07($0.27)--
8/11/2021Q2 2021($0.29)($0.36)($0.07)($0.36)--
5/13/2021Q1 2021($0.33)($0.23)+$0.10($0.23)--  












Evaxion Biotech A/S Earnings - Frequently Asked Questions

When is Evaxion Biotech A/S's earnings date?

Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, December 4th, 2023 based off last year's report dates. Learn more on EVAX's earnings history.

How much profit does Evaxion Biotech A/S generate each year?

Evaxion Biotech A/S (NASDAQ:EVAX) has a recorded net income of -$23.17 million. EVAX has generated -$0.98 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:EVAX) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -